Literature DB >> 17702363

Effects of serum levels of novel atherosclerotic risk factors on aortic valve calcification.

Huseyin Bozbas1, Aylin Yildirir, Ilyas Atar, Bahar Pirat, Serpil Eroglu, Alp Aydinalp, Bulent Ozin, Haldun Muderrisoglu.   

Abstract

BACKGROUND AND AIM OF THE STUDY: Aortic valve calcification (AVC) is a common condition that is found predominantly in the elderly. Clinical and histopathologic data prove that AVC is an active, progressive disease involving an atherosclerotic process. The possible role of novel coronary risk factors in the development of AVC were evaluated.
METHODS: A total of 285 consecutive patients (age >60 years) who had been admitted to the authors' cardiology outpatient clinic was enrolled. Each patient underwent two-dimensional Doppler echocardiography. Serum levels of lipoprotein(a) (Lp(a)), homocysteine (Hcy), uric acid and C-reactive protein (CRP) were monitored and compared between patients with AVC and subjects with otherwise normal aortic valve morphology.
RESULTS: AVC was detected in 112 patients. Compared to controls, patients with AVC were significantly older (73.0 +/- 7.4 versus 68.5 +/- 6.7 years; p <0.0001) and, in addition to higher dyslipidemia, had significantly higher serum levels of Lp(a) (27.4 (range: 13.0-47.5) versus 19.9 (range: 10.7-36.1) mg/dl; p = 0.033) and CRP (6.7 (4.5-10.2) versus 5.6 (3.9-8.0) mg/l; p = 0.008). Serum Hcy and uric acid levels were similar between the groups. Multivariate analysis identified age and serum levels of Lp(a) or CRP as independent determinants of AVC.
CONCLUSION: AVC is common in elderly patients admitted to cardiology clinics. In addition to advanced age, high serum levels of Lp(a) and CRP are independent predictors of the condition.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17702363

Source DB:  PubMed          Journal:  J Heart Valve Dis        ISSN: 0966-8519


  14 in total

Review 1.  Lipoprotein (a) as a cause of cardiovascular disease: insights from epidemiology, genetics, and biology.

Authors:  Børge G Nordestgaard; Anne Langsted
Journal:  J Lipid Res       Date:  2016-09-27       Impact factor: 5.922

Review 2.  Lipoprotein (a) in calcific aortic valve disease: from genomics to novel drug target for aortic stenosis.

Authors:  George Thanassoulis
Journal:  J Lipid Res       Date:  2015-12-18       Impact factor: 5.922

Review 3.  Lipoprotein(a) and oxidized phospholipids in calcific aortic valve stenosis.

Authors:  Calvin Yeang; Michael J Wilkinson; Sotirios Tsimikas
Journal:  Curr Opin Cardiol       Date:  2016-07       Impact factor: 2.161

Review 4.  Genetics of Lipoprotein(a): Cardiovascular Disease and Future Therapy.

Authors:  Anne Langsted; Børge G Nordestgaard
Journal:  Curr Atheroscler Rep       Date:  2021-06-20       Impact factor: 5.113

Review 5.  A review of the effect of diet on cardiovascular calcification.

Authors:  Rachel Nicoll; John McLaren Howard; Michael Y Henein
Journal:  Int J Mol Sci       Date:  2015-04-21       Impact factor: 5.923

6.  Association between homocysteine levels and calcific aortic valve disease: a systematic review and meta-analysis.

Authors:  Guandi Wu; Jiayi Xian; Xi Yang; Jiaying Li; Jichen Liu; Wenhui Dong; Shuwen Su; Jun Li; Yan Tu; Jian Peng; Dingli Xu; Qingchun Zeng
Journal:  Oncotarget       Date:  2018-01-03

7.  Lipoprotein(a) Induces Human Aortic Valve Interstitial Cell Calcification.

Authors:  Bin Yu; Anouar Hafiane; George Thanassoulis; Leah Ott; Nial Filwood; Marta Cerruti; Ophélie Gourgas; Dominique Shum-Tim; Hamood Al Kindi; Benoit de Varennes; Alawi Alsheikh-Ali; Jacques Genest; Adel Schwertani
Journal:  JACC Basic Transl Sci       Date:  2017-08-28

Review 8.  Diet and Lp(a): Does Dietary Change Modify Residual Cardiovascular Risk Conferred by Lp(a)?

Authors:  Byambaa Enkhmaa; Kristina S Petersen; Penny M Kris-Etherton; Lars Berglund
Journal:  Nutrients       Date:  2020-07-07       Impact factor: 5.717

9.  Genetic associations with valvular calcification and aortic stenosis.

Authors:  George Thanassoulis; Catherine Y Campbell; David S Owens; J Gustav Smith; Albert V Smith; Gina M Peloso; Kathleen F Kerr; Sonali Pechlivanis; Matthew J Budoff; Tamara B Harris; Rajeev Malhotra; Kevin D O'Brien; Pia R Kamstrup; Børge G Nordestgaard; Anne Tybjaerg-Hansen; Matthew A Allison; Thor Aspelund; Michael H Criqui; Susan R Heckbert; Shih-Jen Hwang; Yongmei Liu; Marketa Sjogren; Jesper van der Pals; Hagen Kälsch; Thomas W Mühleisen; Markus M Nöthen; L Adrienne Cupples; Muriel Caslake; Emanuele Di Angelantonio; John Danesh; Jerome I Rotter; Sigurdur Sigurdsson; Quenna Wong; Raimund Erbel; Sekar Kathiresan; Olle Melander; Vilmundur Gudnason; Christopher J O'Donnell; Wendy S Post
Journal:  N Engl J Med       Date:  2013-02-07       Impact factor: 91.245

Review 10.  Lipoprotein (a): Recent Updates on a Unique Lipoprotein.

Authors:  Anum Saeed; Sina Kinoush; Salim S Virani
Journal:  Curr Atheroscler Rep       Date:  2021-06-19       Impact factor: 5.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.